Registry-derived stage (RD-Stage) for capturing cancer stage at diagnosis for endometrial cancer.
(MeSH Headings) registries
Cancer
Cancer registries
Epidemiology
Neoplasm staging
TNM Stage
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
12 Dec 2023
12 Dec 2023
Historique:
received:
01
04
2023
accepted:
06
11
2023
medline:
13
12
2023
pubmed:
13
12
2023
entrez:
13
12
2023
Statut:
epublish
Résumé
Capture of cancer stage at diagnosis is important yet poorly reported by health services to population-based cancer registries. In this paper we describe current completeness of stage information for endometrial cancer available in Australian cancer registries; and develop and validate a set of rules to enable cancer registry medical coders to calculate stage using data available to them (registry-derived stage or 'RD-Stage'). Rules for deriving RD-stage (Endometrial carcinoma) were developed using the American Joint Commission on Cancer (AJCC) TNM (tumour, nodes, metastasis) Staging System (8 The necessary data completeness level for calculating RD-Stage (Endometrial carcinoma) across various Australian jurisdictions varied from 0 to 89%. Three jurisdictions captured degree of spread of cancer, rendering RD-Stage unable to be calculated. RD-Stage (Endometrial carcinoma) could not be derived for 64/485 (13%) cases and was not captured for 44/485 (9%) cases in NGOR. At stage category level (I, II, III, IV), there was concordance between RD-Stage and NGOR captured stage in 393/410 (96%) of cases (95.8%, Kendall's coefficient = 0.95). A lack of consistency in data captured by, and data sources reporting to, population-based cancer registries meant that it was not possible to provide national endometrial carcinoma stage data at diagnosis. In a sample of Victorian cases, where surgical pathology was available, there was very good concordance between RD-Stage (Endometrial carcinoma) and clinician-recorded stage data available from NGOR. RD-Stage offers promise in capturing endometrial cancer stage at diagnosis for population epidemiological purposes when it is not provided by health services, but requires more extensive validation.
Sections du résumé
BACKGROUND
BACKGROUND
Capture of cancer stage at diagnosis is important yet poorly reported by health services to population-based cancer registries. In this paper we describe current completeness of stage information for endometrial cancer available in Australian cancer registries; and develop and validate a set of rules to enable cancer registry medical coders to calculate stage using data available to them (registry-derived stage or 'RD-Stage').
METHODOLOGY
METHODS
Rules for deriving RD-stage (Endometrial carcinoma) were developed using the American Joint Commission on Cancer (AJCC) TNM (tumour, nodes, metastasis) Staging System (8
RESULTS
RESULTS
The necessary data completeness level for calculating RD-Stage (Endometrial carcinoma) across various Australian jurisdictions varied from 0 to 89%. Three jurisdictions captured degree of spread of cancer, rendering RD-Stage unable to be calculated. RD-Stage (Endometrial carcinoma) could not be derived for 64/485 (13%) cases and was not captured for 44/485 (9%) cases in NGOR. At stage category level (I, II, III, IV), there was concordance between RD-Stage and NGOR captured stage in 393/410 (96%) of cases (95.8%, Kendall's coefficient = 0.95).
CONCLUSION
CONCLUSIONS
A lack of consistency in data captured by, and data sources reporting to, population-based cancer registries meant that it was not possible to provide national endometrial carcinoma stage data at diagnosis. In a sample of Victorian cases, where surgical pathology was available, there was very good concordance between RD-Stage (Endometrial carcinoma) and clinician-recorded stage data available from NGOR. RD-Stage offers promise in capturing endometrial cancer stage at diagnosis for population epidemiological purposes when it is not provided by health services, but requires more extensive validation.
Identifiants
pubmed: 38087227
doi: 10.1186/s12885-023-11615-6
pii: 10.1186/s12885-023-11615-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1222Informations de copyright
© 2023. The Author(s).
Références
Gilbert N. The pros and cons of screening. Nature. 2020;2020(579):S2-4.
doi: 10.1038/d41586-020-00841-8
Gress D, Edge S, Greene F, Washington M, Asare E, Brierley JE, Byrd D, Compton C, Jessup M, Winchester D et al: Principles of Cancer Staging. In: AJCC Cancer Staging Manual. 8th edn. Edited by Amin ME-i-C. Chicago, Ill: Springer Nature; 2017.
Standards for Cancer Registries Volume II Data Standards and Data Dictionary [ http://datadictionary.naaccr.org/default.aspx?c=1&Version=23 ].
Cone EB, Marchese M, Paciotti M, Nguyen D-D, Nabi J, Cole AP, Molina G, Molina RL, Minami CA, Mucci LA, et al. Assessment of time-to-treatment initiation and survival in a cohort of patients with common cancers. JAMA Netw Open. 2020;3(12):e2030072–e2030072.
doi: 10.1001/jamanetworkopen.2020.30072
pubmed: 33315115
pmcid: 7737088
Yabroff KR, Lund J, Kepka D, Mariotto A. Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev. 2011;20(10):2006–14.
doi: 10.1158/1055-9965.EPI-11-0650
pubmed: 21980008
pmcid: 3191884
Amin M, Edge S, Greene F, Byrd D. Brookland ReaE: AJCC Cancer Staging Manual. 8th ed. Chicago, IL: Springer International Publishing; 2017.
doi: 10.1007/978-3-319-40618-3
Pung L, Moorin R, Trevithick R, Taylor K, Chai K, Garcia Gewerc C, Ha N, Smith S. Determining cancer stage at diagnosis in population-based cancer registries: a rapid scoping review. Front Health Serv. 2023;3:1039266.
doi: 10.3389/frhs.2023.1039266
pubmed: 36926511
pmcid: 10012750
Esteban D, Whelan S, Laudico A, Parkin D: Manual for Cancer Registry Personnel. In. Lyon, France; 1995.
Endometrial Cancer Stages [ https://www.cancer.org/cancer/endometrial-cancer/detection-diagnosis-staging/staging.html ].
Holden RJ. What stands in the way of technology-mediated patient safety improvements? A study of facilitators and barriers to physicians’ use of electronic health records. J Patient Saf. 2011;7(4):193–203.
doi: 10.1097/PTS.0b013e3182388cfa
pubmed: 22064624
pmcid: 3220192
Ratwani R, Fairbanks T, Savage E, Adams K, Wittie M, Boone E, Hayden A, Barnes J, Hettinger Z, Gettinger A. Mind the Gap. A systematic review to identify usability and safety challenges and practices during electronic health record implementation. Appl Clin Inform. 2016;7(4):1069–87.
doi: 10.4338/ACI-2016-06-R-0105
pubmed: 27847961
pmcid: 5228144
Sinaiko AD, Barnett ML, Gaye M, Soriano M, Mulvey T, Hochberg E. Association of peer comparison emails with electronic health record documentation of cancer stage by oncologists. JAMA Netw Open. 2020;3(10):e2015935.
doi: 10.1001/jamanetworkopen.2020.15935
pubmed: 33021649
pmcid: 7539129
Abernethy AP, Herndon JE, Wheeler JL, Rowe K, Marcello J, Patwardhan M. Poor documentation prevents adequate assessment of quality metrics in colorectal cancer. J Oncol Pract. 2009;5(4):167–74.
doi: 10.1200/JOP.0942003
pubmed: 20856630
pmcid: 2795422
Stage, Treatment, and Recurrence (STaR) [ https://www.canceraustralia.gov.au/research/data-and-statistics/cancer-data/improving-cancer-data ].
National Cancer Stage at Diagnosis Data [ https://ncci.canceraustralia.gov.au/features/national-cancer-stage-diagnosis-data ].
Capture of stage data [ https://ncci.canceraustralia.gov.au/diagnosis/distribution-cancer-stage/distribution-cancer-stage ].
Lawrance S, Bui C, Mahindra V, Arcorace M, Cooke-Yarborough C. Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia. BMC Cancer. 2019;19(1):850.
doi: 10.1186/s12885-019-6062-x
pubmed: 31462255
pmcid: 6714314
Meng R, Venugopal K, Thomas H, D’Onise K. Cancer staging at diagnosis data comparisons in South Australia. Scie Rep. 2020;10:1008. https://doi.org/10.1038/s41598-020-57704-5 .
doi: 10.1038/s41598-020-57704-5
National Cancer Control Indicators: distribution of cancer stage [ https://ncci.canceraustralia.gov.au/diagnosis/distribution-cancer-stage/distribution-cancer-stage ].
National Cancer Control Indicators: 5-year relative survival from diagnosis [ https://ncci.canceraustralia.gov.au/outcomes/relative-survival-rate/5-year-relative-survival-diagnosis ].
Victorian Cancer Registry: Cancer in Victoria 2021. In. Melbourne, Vic; 2022.
Uterine cancer statistics and tends: Victorian Cancer Registry [ https://www.cancervic.org.au/research/vcr/cancer-fact-sheets/uterine-cancer.html ].
Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin LH, Parkin DM, Whelan S, al. reWHO: International classification of diseases for oncology (ICD-0)- 3rd edition Geneva: World Health Organization,; 2000 with 1st (2013) and 2nd (2019) revisions.
Australian Commission on Safety and Quality in Health Care: Framework for Australain Clinical Quality Registries. In. Sydney, NSW; 2014.
Heriot N, Brand A, Cohen P, Hegarty S, Hyde S, Leung Y, Zalcberg JR, Rome R. Developing an Australian multi-module clinical quality registry for gynaecological cancers: a protocol paper. BMJ Open. 2020;10(2):e034579.
doi: 10.1136/bmjopen-2019-034579
pubmed: 32111617
pmcid: 7050311
National Gynae-Oncology Registry: Ovarian Cancer Registry Annual Report: July 2022- December 2021. In. Melbourne, Vic; 2022.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74.
doi: 10.2307/2529310
pubmed: 843571
Cancer Registration User Guide [ https://www.cancervic.org.au/research/vcr/submitting-data ]
Centers for Disease Control and Prevention: Incidence and Relative Survival by Stage at Diagnosis for Common Cancers. In., vol. USCS Data Brief, no. 25. Atlanta, GA; 2021.
Cancer Registration Statistics, England 2020. Cancer incidence by stage. [ https://digital.nhs.uk/data-and-information/publications/statistical/cancer-registration-statistics/england-2020/cancer-incidence-by-stage ].
Piñeros M, Parkin DM, Ward K, Chokunonga E, Ervik M, Farrugia H, Gospodarowicz M, O’Sullivan B, Soerjomataram I, Swaminathan R, et al. Essential TNM: a registry tool to reduce gaps in cancer staging information. Lancet Oncol. 2019;20(2):e103–11.
doi: 10.1016/S1470-2045(18)30897-0
pubmed: 30712797
User's Guide to Essential TNM (E TNM) [ https://www.uicc.org/sites/default/files/atoms/files/Essential%20TNM%20Users%20Guide_Version%203_8%20sites%201%20Apr%202022_ENG.pdf ].
Parkin DM, Liu B, Adoubi I, Makouanzi AS, Masalu N, Mrema C, Ndlovu N, Omonisi A, Traore B, Joko-Fru Y. Enhancing information on stage at diagnosis of cancer in Africa. Acta Oncol. 2023;62(4):335–41.
doi: 10.1080/0284186X.2023.2205548
pubmed: 37102435
Walters S, Maringe C, Butler J, Brierley JD, Rachet B, Coleman MP. Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership. Int J Cancer. 2013;132(3):676–85.
doi: 10.1002/ijc.27651
pubmed: 22623157
Nguyen AN, Moore J, O’Dwyer J, Philpot S. Assessing the utility of automatic cancer registry notifications data extraction from free-text pathology reports. AMIA Annu Symp Proc. 2015;2015:953–62.
pubmed: 26958232
pmcid: 4765645
Electronic Pathology Solutions [ https://www.cancer.nsw.gov.au/research-and-data/cancer-data-and-statistics/submit-cancer-cases-to-the-nsw-cancer-registry/electronic-pathology-solutions ].
E-Path project [ https://www.cancervic.org.au/research/vcr/recruitment-and-research-studies/e-path ].
McCluggage WG, Colgan T, Duggan M, Hacker NF, Mulvany N, Otis C, Wilkinson N, Zaino RJ, Hirschowitz L. Data set for reporting of endometrial carcinomas: recommendations from the International Collaboration on Cancer Reporting (ICCR) between United Kingdom, United States, Canada, and Australasia. Int J Gynecol Pathol. 2013;32(1):45–65.
doi: 10.1097/PGP.0b013e31825d808b
pubmed: 23202790
Matias-Guiu X, Selinger CI, Anderson L, Buza N, Ellenson LH, Fadare O, Ganesan R, Ip PPC, Palacios J, Parra-Herran C, et al. Data set for the reporting of endometrial cancer: recommendations from the International Collaboration on Cancer Reporting (ICCR). Int J Gynecol Pathol. 2022;41(Suppl 1):S90-s118.
doi: 10.1097/PGP.0000000000000901
pubmed: 36305536
Structured pathology reporting of cancer- protocols [ https://www.rcpa.edu.au/Library/Practising-Pathology/Structured-Pathology-Reporting-of-Cancer/Cancer-Protocols ].
National Pathology Accreditation Advisory Council: Requirements for Information Communication and Reporting (Fourth Edition 2020). In. Edited by Department of Health and Aged Care AG. Canberra, ACT; 2021.
What we're doing about pathology: Pathology accreditation [ https://www.health.gov.au/topics/pathology/what-were-doing-about-pathology?utm_source=health.gov.au&utm_medium=callout-auto-custom&utm_campaign=digital_transformation#pathology-accreditation ].
Fass L. Imaging and cancer: a review. Mol Oncol. 2008;2(2):115–52.
doi: 10.1016/j.molonc.2008.04.001
pubmed: 19383333
pmcid: 5527766
Cancer Australia: The Australian Cancer Plan: building the future. Consultation Draft. In. Surry Hills, NSW; 2022.